Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Citius Pharmaceuticals, Inc. CTXR

Full chart Compare
Set alert

Price alert · CTXR

All alert types
0.55 USD -0.02 (-3.87%)

Nov 4, 2026, 3:53 PM EST

0.5422 Day range 0.5708
0.37 52-week range 1.54
YTD
-29.09%
1 year
-59.49%

Financial health

Altman Z-Score

-4.03 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -0.4×
FY 2016: -103×FY 2017: -41.7×FY 2018: -35.7×FY 2019: -24.6×FY 2020: -2.3×FY 2021: -9.0×FY 2022: -5.3×FY 2023: -3.1×FY 2024: -2.1×FY 2025: -0.4×
FY 2016 5y median -3.1× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.2×
FY 2016: 3.4×FY 2017: 1.3×FY 2018: 1.1×FY 2019: 1.0×FY 2020: 1.2×FY 2021: 1.7×FY 2022: 1.7×FY 2023: 1.1×FY 2024: 2.1×FY 2025: 0.2×
FY 2016 5y median 1.7× FY 2025
P/FCF -0.5×
FY 2016: -9.7×FY 2017: -3.6×FY 2018: -2.6×FY 2019: -2.0×FY 2020: -2.4×FY 2021: -3.4×FY 2022: -6.2×FY 2023: -3.6×FY 2024: -5.1×FY 2025: -0.5×
FY 2016 5y median -3.6× FY 2025
EV/EBITDA -0.3×
FY 2016: -7.7×FY 2017: -2.6×FY 2018: -1.5×FY 2019: -1.1×FY 2020: -1.6×FY 2021: -6.5×FY 2022: -4.1×FY 2023: -2.1×FY 2024: -3.7×FY 2025: -0.3×
FY 2016 5y median -3.7× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -193.5%
FY 2016: -10.3%FY 2017: -27.7%FY 2018: -37.9%FY 2019: -48.9%FY 2020: -41.6%FY 2021: -29.1%FY 2022: -16.0%FY 2023: -28.1%FY 2024: -19.4%FY 2025: -193.5%
FY 2016 5y median -28.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -55.4%
FY 2016: -49.5%FY 2017: -47.3%FY 2018: -45.0%FY 2019: -63.9%FY 2020: -52.1%FY 2021: -17.4%FY 2022: -32.7%FY 2023: -35.8%FY 2024: -55.9%FY 2025: -55.4%
FY 2016 5y median -35.8% FY 2025
ROIC -44.2%
FY 2016: -42.7%FY 2017: -45.1%FY 2018: -49.2%FY 2019: -63.5%FY 2020: -44.3%FY 2021: -17.0%FY 2022: -30.4%FY 2023: -37.5%FY 2024: -51.8%FY 2025: -44.2%
FY 2016 5y median -37.5% FY 2025
ROA -28.6%
FY 2016: -37.8%FY 2017: -42.5%FY 2018: -40.4%FY 2019: -53.7%FY 2020: -40.1%FY 2021: -16.2%FY 2022: -29.5%FY 2023: -31.4%FY 2024: -33.6%FY 2025: -28.6%
FY 2016 5y median -29.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 8.3%
FY 2016: -130.6%FY 2017: -34.1%FY 2018: -38.1%FY 2019: -13.1%FY 2020: -13.5%FY 2021: -32.9%FY 2022: -41.6%FY 2023: -10.3%FY 2024: -14.3%FY 2025: 8.3%
FY 2016 FY 2025
EPS (diluted) 43.4%
FY 2016: -67.2%FY 2017: 17.5%FY 2018: 38.1%FY 2019: 34.2%FY 2020: -1354.5%FY 2021: 49.6%FY 2022: -2.0%FY 2023: 3.1%FY 2024: -7.2%FY 2025: 43.4%
FY 2016 FY 2025
Free Cash Flow 5.8%
FY 2016: -147.4%FY 2017: -35.1%FY 2018: -41.9%FY 2019: -9.9%FY 2020: -36.1%FY 2021: -279.5%FY 2022: 55.9%FY 2023: -2.5%FY 2024: 3.0%FY 2025: 5.8%
FY 2016 FY 2025

Financial Health

Current Ratio 0.6×
FY 2016: 0.2×FY 2017: 1.4×FY 2018: 3.2×FY 2019: 1.7×FY 2020: 3.4×FY 2021: 18.3×FY 2022: 9.8×FY 2023: 5.9×FY 2024: 0.4×FY 2025: 0.6×
FY 2016 5y median 5.9× FY 2025
Quick Ratio 0.1×
FY 2016: 0.2×FY 2017: 1.4×FY 2018: 3.2×FY 2019: 1.7×FY 2020: 3.4×FY 2021: 18.3×FY 2022: 9.8×FY 2023: 5.9×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 5.9× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: -0.1×FY 2017: 0.3×FY 2018: 0.7×FY 2019: 0.5×FY 2020: 0.7×FY 2021: 3.0×FY 2022: 1.2×FY 2023: 0.7×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.7× FY 2025
Interest Coverage -144×
FY 2016: -828×FY 2017: -11.7×FY 2018: -871×FY 2019: -949×FY 2020: -1130×FY 2021: -2171×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -144×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30